DuLac Farmaceutici is accelerating its push into the U.S. market, announcing that its Italian-developed products are now available through OneLavi.com as the company prepares to take part in the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session, held September 14-17 in Palm Beach Gardens, Florida.

The two moves mark significant steps in DuLac's strategy to substantially expand its presence in the United States. Having already built consumer demand through Amazon U.S., the Italian pharmaceutical company is adding a new e-commerce channel while preparing to introduce its brand and product portfolio to the major U.S. retailers attending ECRM. ECRM's sessions are efficient, pre-scheduled meeting formats that connect brands directly with retail buyers, bypassing the traditional trade-show booth model, which makes the event a common entry point for foreign suppliers seeking U.S. retail shelf placement.

DuLac regards the United States as a significant long-term growth market and is structuring its expansion accordingly. Rather than depending on a single sales channel, the company is constructing a broader U.S. presence that combines established Amazon demand, expanded e-commerce availability through OneLavi, and direct engagement with retailers and distribution partners.

"ECRM comes at an important time for DuLac because we are making a major commitment to the U.S. market," said Gabriele Bollani, Founder and CEO of DuLac Farmaceutici. "Amazon has demonstrated that American consumers are responding to our products, OneLavi gives us another important U.S. channel, and now we are ready to introduce DuLac to major retailers and build the partnerships that can take our expansion to the next level."

DuLac enters this next phase with an established base of U.S. consumer demand. Consumer response on Amazon continues to underscore the company's growing U.S. presence: Arnica Gel 98% has earned more than 13,000 customer reviews with an average 4.5-star rating, while the Dinaven line has received more than 4,000 customer reviews and maintains an average 4.6-star rating. That consumer traction matters because U.S. retail buyers routinely weigh demonstrated online sales performance when deciding whether to stock emerging brands, giving companies with established e-commerce demand a stronger pitch.

The addition of OneLavi represents the next step in broadening that footprint. DuLac products are now available to OneLavi customers, giving the company another platform through which to introduce its Made in Italy portfolio to American consumers.

DuLac's participation at ECRM adds an important business-to-business dimension to the U.S. expansion. During the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session, DuLac will take part in scheduled meetings with buyers representing major health, specialty, food, drug, and mass retail channels, creating an opportunity to present the company's Italian-developed product portfolio, pharmaceutical heritage, and advanced manufacturing capabilities to potential U.S. retail partners.

Among the products DuLac will highlight are its high-concentration Arnica Gel 98% range and the Dinaven and Diosmin lines. For the company, the objective extends beyond gaining additional points of distribution: DuLac is using ECRM to establish relationships that can support a much larger and more diversified U.S. retail presence as it advances its national expansion strategy.

DuLac brings more than 30 years of pharmaceutical industry expertise and pharmacy-channel experience in Italy to its U.S. expansion. Its product development and manufacturing capabilities include the proprietary Arnica Montana Arricchita project, indoor vertical farming, micronized Diosmin MPFF technology, solvent-free Supercritical CO₂ extraction, and manufacturing under internationally recognized GMP and ISO quality frameworks. Those quality certifications and traceable production processes are the kind of credentials U.S. retailers and regulators expect from suppliers in the vitamins and supplements category, where product quality claims are closely scrutinized.

This combination of Italian pharmaceutical heritage, research, advanced production technologies, established Amazon consumer demand, and growing U.S. distribution forms the foundation for DuLac's next stage of growth. With Amazon already established, OneLavi now live, and scheduled meetings with major retail buyers planned through ECRM, DuLac is transitioning from initial U.S. market development toward a broader national expansion strategy. The company's goal is to build a diversified U.S. presence across e-commerce, retail, wholesale, and other distribution channels while introducing more American consumers to the DuLac brand and its Italian-developed product portfolio. How effectively the ECRM meetings convert into retail partnerships will be a key indicator to watch as the expansion progresses.